Clinical trial
Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a…
NCT05779631 · Radboud University Medical Center, Other · Recruiting
Key facts
| NCT number | NCT05779631 |
|---|---|
| Title | Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm |
| Official title | Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm (BladParadigm) |
| Acronym | BladParadigm |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Recruiting |
| Study type | Interventional |
| Conditions | Bladder Cancer, Muscle-invasive Bladder Cancer |
| Intervention type | Diagnostic Test, Procedure |
| Interventions | mpMRI plus a same-day cystoscopic bladder biopsy, TURBT |
| Enrollment | 360 |
| Start date | Dec 6, 2023 |
| Primary completion | Dec 1, 2028 |
| Completion | Jun 1, 2031 |
| First posted | Mar 22, 2023 |
| Last update posted | Jan 8, 2026 |
| Countries | Netherlands |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: